- 'Benghazi'-Like Hearing Unlikely For Califf, But Expect Questions
- US Capitol Capsule: Clearing FDA's Generics Backlog Answer To Drug Price Controversy?
- Speed Up Access To Cancer Drugs, Australia's Senate Tells Government
- 'Often Reserved' FDA Biologics Chief Midthun To Depart
ANALYSIS Other Informa Analysis
- The EMA at 20: Guido Rasi looks at how the EU regulatory landscape might change over the next decade
- INTERVIEW: Collaboration key for China regulatory reforms, RDPAC says (Part 2)